Procurement Summary
Country: Kazakhstan
Summary: Purchase Antibotulinum Serum, Amt: 105000.00
Deadline: 22 Jun 2026
Posting Date: 21 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143708652
Document Ref. No.: 17209358-1
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 105000.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Lots: Anti-botulinum serum type B horse purified concentrated liquid 10000 IU No. 5 • Active ingredient: Highly purified specific immunoglobulins obtained from the blood serum of hyperimmunized horses. • Release form: Liquid solution for injection, packaged in ampoules. • Dosage: Contains at least 2500 IU (international units) of antitoxin per ml. The therapeutic dose of the drug is at least 10, 000 IU. • Types: Available as monovalent (versus types A, B or E) and polyvalent serums. • Appearance: Transparent or slightly opalescent yellowish liquid. | Equine anti-botulinum serum type E purified concentrated liquid 10000 IU No. 5 • Active ingredient: Highly purified specific immunoglobulins obtained from the blood serum of hyperimmunized horses. • Release form: Liquid solution for injection, packaged in ampoules. • Dosage: Contains at least 2500 IU (international units) of antitoxin per ml. Therapeutic dose of the drug is at least 10, 000 IU. • Types: Available as monovalent (against types A, B or E) and polyvalent serums. • Appearance: Transparent or slightly opalescent yellowish liquid. | Antibotulinum serum type A for horses purified concentrated liquid 10000 IU#5 • Active ingredient: Highly purified specific immunoglobulins obtained from the blood serum of hyperimmunized horses. • Release form: Liquid solution for injection...
Documents
Tender Notice